2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow SLE: new trials by email Literature Review of SLE trials Research Report on SLE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| JBT-101 in Systemic Lupus Erythematosus (SLE) JBT-101, Placebo - Systemic Lupus Erythematosus, SLE | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 109 | 2017-12-21 | 2026-05-06 |
| Vitamin D3 in Systemic Lupus Erythematosus Vitamin D3, Vitamin D3 placebo - Systemic Lupus Erythematosus, SLE | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 57 | 2008-11-01 | 2017-04-26 |
Lupus Erythematosus, Systemic (2) · Musculoskeletal Diseases (1) · Vitamin D Deficiency (1)
Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Skin and Connective Tissue Diseases (2) · Avitaminosis (1) · Deficiency Diseases (1) · Malnutrition (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1)
Cholecalciferol (1) · anabasum (1) · lenabasum (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2)
United States (2)
Cynthia Aranow, MD (1) · Diane Kamen, MD (1) · Meggan Mackay, M.D., M.S. (1) · Robert B. Zurier, M.D. (1)
UM1AI110494 (1)